Group 1 - The stock of Beyond (BYON) has gained 63.4% over the past four weeks, with a mean price target of $12 indicating an 80.5% upside potential from the current price of $6.65 [1] - The mean estimate consists of six short-term price targets, with the lowest at $5 (24.8% decline) and the highest at $36 (441.4% increase), highlighting a standard deviation of $12.07 which indicates variability among analysts [2] - Analysts show strong agreement on BYON's ability to report better earnings than previously predicted, which supports the view of potential upside [4][11] Group 2 - The Zacks Consensus Estimate for BYON's current year earnings has increased by 29.8% over the last 30 days, with four estimates moving higher and no negative revisions [12] - BYON holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for near-term upside [13] - While price targets can be misleading, the direction implied by the consensus price target for BYON appears to be a good guide for potential price movement [10][13]

Intapp (INTA) closed the last trading session at $55.04, gaining 1.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $71 indicates a 29% upside potential.The average comprises eight short-term price targets ranging from a low of $60 to a high of $83, with a standard deviation of $7.95. While the lowest estimate indicates an increase of 9% from the current price level, the most opt ...

Group 1 - The core viewpoint is that Inspired Entertainment (INSE) has significant upside potential, with a mean price target of $12.40 indicating a 56.6% increase from its current price of $7.92 [1] - Analysts have set short-term price targets ranging from $10 to $16, with the lowest estimate suggesting a 26.3% increase and the highest indicating a 102% upside [2] - The standard deviation of $2.30 among the price targets suggests a moderate level of agreement among analysts regarding the stock's potential movement [2] Group 2 - Analysts are optimistic about INSE's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 78.3%, with two estimates moving higher and no negative revisions [12] - INSE holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for near-term upside [13]

Core Viewpoint - Tetra Tech (TTEK) shows potential as a strong investment opportunity due to significant revisions in earnings estimates, indicating an improving earnings outlook and potential for continued stock price gains [1][2]. Earnings Estimate Revisions - Analysts have become increasingly optimistic about Tetra Tech's earnings prospects, as reflected in the upward trend of estimate revisions, which typically correlate with stock price movements [2]. - The current-quarter earnings estimate is projected at $0.37 per share, representing a year-over-year increase of +15.63%. Over the past 30 days, the Zacks Consensus Estimate has risen by 8.82% with no negative revisions [6]. - For the full year, the earnings estimate stands at $1.47 per share, reflecting a +16.67% change from the previous year. The consensus estimate has increased by 7.3% during this period, with one estimate moving higher and no negative revisions [7][8]. Zacks Rank and Performance - Tetra Tech currently holds a Zacks Rank 2 (Buy), indicating strong agreement among analysts regarding the positive earnings revisions. This ranking is part of a system that has historically shown that Zacks 1 (Strong Buy) and 2 (Buy) stocks significantly outperform the S&P 500 [9]. - The Zacks Rank system has demonstrated an impressive track record, with Zacks 1 Ranked stocks generating an average annual return of +25% since 2008 [3]. Stock Performance - Tetra Tech's stock has appreciated by 15.8% over the past four weeks, driven by strong estimate revisions and positive investor sentiment, suggesting further upside potential [10].

Group 1 - American Superconductor (AMSC) shares have increased by 35.4% in the past four weeks, closing at $27.38, with a mean price target of $39 indicating a potential upside of 42.4% [1] - The average price targets from analysts range from a low of $38 to a high of $40, with a standard deviation of $1, suggesting a strong agreement among analysts regarding the stock's potential movement [2] - Analysts are optimistic about AMSC's earnings prospects, as indicated by positive revisions in earnings estimates, which historically correlate with stock price movements [4][9] Group 2 - The Zacks Consensus Estimate for AMSC has increased by 2.5% due to two upward revisions in earnings estimates over the last 30 days, with no negative revisions [10] - AMSC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [11] - While price targets may not be entirely reliable, the direction they imply can serve as a useful guide for investors [11]

Shares of Encore Capital Group (ECPG) have gained 11.1% over the past four weeks to close the last trading session at $39.04, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $57.25 indicates a potential upside of 46.6%.The average comprises four short-term price targets ranging from a low of $55 to a high of $61, with a standard deviation of $2.63. While the lowest estimate indi ...

Shares of ODP Corp. (ODP) have gained 18.5% over the past four weeks to close the last trading session at $16.05, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $31 indicates a potential upside of 93.2%.The average comprises three short-term price targets ranging from a low of $17 to a high of $41, with a standard deviation of $12.49. While the lowest estimate indicates an incr ...

Core Viewpoint - Kezar Life Sciences, Inc. (KZR) has received an upgrade to a Zacks Rank 2 (Buy), indicating a positive outlook driven by rising earnings estimates, which significantly influence stock prices [1][4][6]. Earnings Estimates and Stock Performance - The Zacks rating system focuses on a company's changing earnings picture, with the Zacks Consensus Estimate tracking EPS estimates from sell-side analysts [2]. - Changes in earnings estimates are strongly correlated with near-term stock price movements, largely due to institutional investors adjusting their valuations based on these estimates [5][7]. - For Kezar Life Sciences, the Zacks Consensus Estimate for the fiscal year ending December 2025 is projected at -$8.19 per share, reflecting a 27.5% change from the previous year [9]. Zacks Rating System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have averaged a +25% annual return since 1988 [8]. - The upgrade of Kezar Life Sciences to a Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [10][11].

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?Let's take a look at what these Wall Street heavyweights have to say about Synchronoss (SNCR) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.Synchronoss currently has an average br ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about AZZ (AZZ) .AZZ currently has an average brokerage recommendation (ABR) of 1.50, on a scale of 1 ...